arXiv:2606.05616v1 Announce Type: new Abstract: The morphological form of a word can often give cues to its meaning, but purely relying on these mappings can lead to overgeneralization in high-stakes domains. In the medical domain, for instance, LLMs can confidently reason about fictitious drugs from their affixes alone (e.g., wugcillin) and generate plausible-looking clinical content. We present a behavioral and mechanistic study of LLM "affix heuristics" in pharmacology. Using fictitious drug names built from real affixes, we show that affix signals alone elicit class-level pharmacological r
The proliferation of Large Language Models (LLMs) into high-stakes domains like medicine necessitates ongoing research into their reliability and potential biases, such as overgeneralization from morphological cues.
This research highlights a critical vulnerability in LLMs, where superficial linguistic patterns can lead to plausible but incorrect medical reasoning, posing risks in pharmaceutical development, diagnosis, and patient care.
Increased awareness of LLM 'affix heuristics' will drive demand for more robust validation and explainability in AI applications for sensitive fields, potentially leading to new adversarial training methods.
- · AI Safety Researchers
- · Healthcare AI Developers (focused on robustness)
- · Regulatory Bodies
- · LLM Developers (without robust safety measures)
- · Early adopters of unvalidated medical AI
The immediate effect is a clearer understanding of how LLMs form associations, particularly in specialized vocabularies like pharmacology.
This understanding will likely lead to the development of better fine-tuning strategies or architectural modifications to mitigate such morphological shortcuts.
Ultimately, this could foster greater trust in AI for medical applications, once these vulnerabilities are adequately addressed and validated through rigorous testing.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.CL